Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Is the Juice Worth the Squeeze in Clover Health Investments Stock?

By Chris Markoch, InvestorPlace Contributor
CLOV stock looks to be setting up for a short squeeze. But that runs the risk of papering over the obstacles that Clover Health needs to overcome.

3 New Reasons To Sell Robinhood Now

By Wayne Duggan, InvestorPlace Contributor
Robinhood put up some extremely impressive growth numbers in the second quarter. But that growth won't last, and HOOD stock is a huge gamble.

The Odds Are Firmly Against Ocugen Stock Now

By Muslim Farooque, InvestorPlace Contributor
OCGN stock is a remarkably risky Covid-19 vaccine play, as the company faces a myriad of regulatory roadblocks on different fronts.

Clover Health: Insurance Losses Lead to Anemic Stock Price

By Ian Bezek, InvestorPlace Contributor
Clover Health has been a disappointing situation all year long. And things went from bad to worse for CLOV stock following dour Q2 earnings.

Zomedica Needs to Start Delivering Tangible Results

By Ian Bezek, InvestorPlace Contributor
Zomedica has an interesting story that could work out. However, the company's inability to execute is raising key concerns about ZOM stock.

Carnival Stock Continues to Carry Weight of the ‘Unwanted’ Passenger

By Will Ashworth, InvestorPlace Contributor
Carnival’s customers are still getting Covid-19 on its ships. That's not good news for CCL stock. At this point, buyers should beware. 

Square Stock Is so Much More Vulnerable as It Adds Even More Credit Risk

By Dana Blankenhorn, InvestorPlace Contributor
With a credit card, the risk is on the bank. With Buy Now, Pay Later, it's on the merchant. Those predicting Square will soon outrun JPMorgan Chase aren't accounting for those risks.

Novavax Is Selling a Dream, But You Should Live in Reality

By Stavros Georgiadis, CFA, InvestorPlace Contributor
The price of NVAX stock reflects hope in the company's Covid-19 vaccine, but hope doesn't change their poor fundamentals.

DiDi Stock Could Drop by Two-Thirds if the Company Leaves China

By Mark R. Hake, CFA
DiDi's Chinese business has been gutted by regulators removing its app from app stores, which is terrible news for DIDI stock.

Big Gains On AMC Stock Could Backfire On New Investors

By Wayne Duggan, InvestorPlace Contributor
Many first-time investors have made a killing on AMC stock in 2021. Unfortunately, they may be learning some bad investing habits.

SNDL Stock Remains Little More Than a Squeeze Play, Save Your Money

By Alex Sirois, InvestorPlace Contributor
SNDL stock is as fundamentally unappealing as it was before which is why investors shouldn't put their capital into it.

Tilray Stock Looks Worse and Worse, and M&A Isn’t Helping

By Alex Sirois, InvestorPlace Contributor
TLRY stock shouldn't interest investors along with the broader cannabis sector. Too much hope, too little results.

Let Support.com Stock Retrace to $5 Before Placing Your Order

By David Moadel, InvestorPlace Contributor
You might be tempted to buy SPRT stock prior to its upcoming merger, but check the company's financial data before jumping into the trade.

Nio Stock Won’t Rebound Soon, and Its Future Is Far From Settled

By Thomas Niel, InvestorPlace Contributor
Long-term, shares could hit prices well above the high it made earlier this year. Yet that doesn't mean it will stop trending lower anytime soon. Even if it meets or beats projections in the quarters ahead. With this in mind, it's best to continue avoiding NIO stock.

Promises Seeking to Buoy ContextLogic Stock Amount to WISH-ful Thinking

By David Moadel, InvestorPlace Contributor
It's hard to recommend WISH stock after top- and bottom-line misses and multiple ContextLogic downgrades from respected Wall Street analysts.

Corsair Stock Can’t Overcome Its Reliance on Meme Money

By Larry Ramer, InvestorPlace Contributor
With Corsair stock facing many challenges and meme stocks losing ground, investors should avoid CRSR stock for now.

There’s a Warning for GameStop in Robinhood’s Earnings

By Ian Bezek, InvestorPlace Contributor
People own GME stock for memes, not fundamentals. Unfortunately for GameStop, the meme crowd is now turning to crypto instead.

Now Is Not the Time To Get Greedy With DiDi Global

By David Moadel, InvestorPlace Contributor
As China continues to impose restrictions on Chinese technology firms, the downtrend in DIDI stock is likely to persist for a while longer.

Why It Was Time To Sell My Facebook Stock

By Dana Blankenhorn, InvestorPlace Contributor
Facebook, and FB stock, is facing increased pressure from government to grow up and support values beyond the company's self-interest.
Load More Articles